Eledon Pharmaceuticals (ELDN) CEO David-Alexandre Gros on Q2 2021 Results - Earnings Call Transcript
Eledon Pharmaceuticals (ELDN) CEO David-Alexandre Gros on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Elite Pharmaceuticals, Inc. (ELTP) CEO Narsat Hakim on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Processa Pharmaceuticals' (PCSA) CEO David Young on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha